Abstract
Phenylacetate inhibits protein isoprenylation and growth of the androgen-independent LNCaP prostate cancer cells transfected with the T24 Ha-ras oncogene.
R Danesi, D Nardini, F Basolo, M Del Tacca, D Samid and C E Myers
Molecular Pharmacology June 1996, 49 (6) 972-979;